AUSTIN, Texas -- Austin-based medical keyboard manufacturer iKey announces its support for the Committee to Reduce Infection Deaths (RID), a non-profit educational organization dedicated to stopping hospital infections. RID has recognized iKey products as innovative technologies intended to help prevent cross contamination in medical environments and the deaths relating to hospital-acquired infections (HAIs) they can cause.
With technology becoming ever more present in patient rooms and operating facilities, the risk of acquiring and spreading infection through instruments, such as keyboards, is growing. To combat this risk, iKey has developed the FL-Series of cleanable medical keyboards and mice that are easily disinfected with bleach or germicidals and effectively protect patients and caregivers from infection.
"Research shows that keyboards are a vector for disease in hospitals. Products that remove this hazard will help save lives," says Betsy McCaughy, PhD, founder and chair of the Committee to Reduce Infection Deaths.Â
Products in iKeys FL Series can be disinfected against harmful diseases quickly with a simple wipe down, which makes them ideal for patient rooms, carts, retractable workstations, operating rooms or the ICU. While other sealed keyboards require rinsing under soapy water, the FL-Series can be cleaned onsite without shutting down the computer system. In addition, the keyboards have backlighting for convenient use in low-light environments and feature low-profile keys to ensure effective cleaning.
iKey applauds the advancements RID has made in educating the medical community on the risks of hospital-acquired infections. They have shown that taking precautions with technology, such as installing keyboards that medical professionals can easily disinfect, is a critical element of responsible infection control, says Joel East, technical design Engineer for iKey. Were proud to support RID and give medical professionals everywhere the tools they need to provide safe environments for their patients and themselves.
Source: iKey
Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
2 Commerce Drive
Cranbury, NJ 08512